MedPath

Diclofenac vs Dexamethasone in Combined Surgery

Not Applicable
Completed
Conditions
Cataract
Glaucoma
Interventions
Registration Number
NCT00825864
Lead Sponsor
Sheba Medical Center
Brief Summary

To study the effect of Diclofenac drops or Dexamethasone drops on combined surgery of trabeculectomy and cataract surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patients scheduled for combines surgery of trabeculectomy and cataract surgery
Exclusion Criteria
  • severe complicated surgery like vitreal loss, expulsive hemorrhage, endophthalmitis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1diclofenac drops treatmentdiclofenac dropsfour times a day for 3 months
2dexamethasone dropsdexamethasone sodium phosphate 0.1% eye drops-
Primary Outcome Measures
NameTimeMethod
intraocular pressureyear
Secondary Outcome Measures
NameTimeMethod
the number of antiglaucoma medicationsyear

Trial Locations

Locations (1)

Goldschleger Eye Institute, Sheba Medcial Center

🇮🇱

Tel-Hashomer, Israel

© Copyright 2025. All Rights Reserved by MedPath